featured
Topical Rapamycin Effective for Angiofibroma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First Left-Right Comparative Study of Topical Rapamycin Versus Vehicle for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex
Br J Dermatol 2013 Dec 01;169(6)1314–1318, M Tanaka, M Wataya-Kaneda, A Nakamura, S Matsumoto, I KatayamaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.